Jpmorgan Chase & CO Biolife Solutions Inc Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Biolife Solutions Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 243,278 shares of BLFS stock, worth $5.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

243,278

Previous 253,585 4.06%

Holding current value

$5.32 Million

Previous $6.58 Million 15.6%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$22.84 - $28.49 $235,411 - $293,646	-10,307 Reduced 4.06%	243,278 $5.56 Million
Q4 2024 Feb 12, 2025	SELL	$20.47 - $27.47 $506,591 - $679,827	-24,748 Reduced 8.89%	253,585 $6.58 Million
Q3 2024 Dec 26, 2024	SELL	$19.19 - $26.52 $142,044 - $196,301	-7,402 Reduced 2.59%	278,333 $6.97 Million
Q3 2024 Nov 08, 2024	SELL	$19.19 - $26.52 $142,044 - $196,301	-7,402 Reduced 2.59%	278,333 $6.97 Million
Q2 2024 Dec 26, 2024	BUY	$15.14 - $22.99 $112,066 - $170,171	7,402 Added 2.66%	285,735 $6.12 Million
Q2 2024 Aug 12, 2024	SELL	$15.14 - $22.99 $745,084 - $1.13 Million	-49,213 Reduced 14.69%	285,735 $6.12 Million
Q1 2024 Dec 26, 2024	BUY	$15.35 - $18.82 $869,040 - $1.07 Million	56,615 Added 20.34%	334,948 $6.21 Million
Q1 2024 May 10, 2024	SELL	$15.35 - $18.82 $304,728 - $373,614	-19,852 Reduced 5.6%	334,948 $6.21 Million
Q4 2023 Dec 26, 2024	BUY	$8.99 - $16.86 $687,438 - $1.29 Million	76,467 Added 27.47%	354,800 $5.77 Million
Q4 2023 Feb 12, 2024	SELL	$8.99 - $16.86 $175,673 - $329,461	-19,541 Reduced 5.22%	354,800 $5.77 Million
Q3 2023 Nov 14, 2023	SELL	$10.81 - $22.96 $312,365 - $663,452	-28,896 Reduced 7.17%	374,341 $5.17 Million
Q2 2023 Aug 11, 2023	SELL	$17.19 - $24.34 $34,912 - $49,434	-2,031 Reduced 0.5%	403,237 $8.91 Million
Q1 2023 May 18, 2023	BUY	$17.67 - $26.07 $752,335 - $1.11 Million	42,577 Added 11.74%	405,268 $8.81 Million
Q1 2023 May 11, 2023	SELL	$17.67 - $26.07 $730,248 - $1.08 Million	-41,327 Reduced 10.23%	362,691 $7.89 Million
Q4 2022 Feb 13, 2023	SELL	$16.95 - $25.07 $28,001 - $41,415	-1,652 Reduced 0.41%	404,018 $7.35 Million
Q3 2022 Nov 14, 2022	SELL	$14.64 - $26.7 $719,980 - $1.31 Million	-49,179 Reduced 10.81%	405,670 $9.23 Million
Q2 2022 Aug 11, 2022	BUY	$10.54 - $24.2 $162,284 - $372,607	15,397 Added 3.5%	454,849 $6.28 Million
Q1 2022 May 11, 2022	SELL	$20.81 - $37.29 $668,479 - $1.2 Million	-32,123 Reduced 6.81%	439,452 $9.99 Million
Q4 2021 Feb 10, 2022	BUY	$32.99 - $58.55 $2.69 Million - $4.77 Million	81,435 Added 20.87%	471,575 $17.6 Million
Q3 2021 Nov 12, 2021	BUY	$42.03 - $60.5 $16.4 Million - $23.6 Million	390,140 New	390,140 $16.5 Million

Others Institutions Holding BLFS

# of Institutions

202

Shares Held

48.8M

Call Options Held

2.5K

Put Options Held

182K

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $934M
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Biolife Solutions Inc Transaction History